X Marks the Sex-Skewed Spot

Alterations in epigenetic markers on the X chromosome may be why males outnumber females among murine offspring bred through in vitro fertilization.

Written byRina Shaikh-Lesko
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Intracytoplasmic sperm injection of a human oocyteWIKIMEDIA, EUGENE ERMOLOVICHOffspring conceived by in vitro fertilization (IVF) are more likely to be male than female. Now, a team led by Jianhui Tian of China Agricultural University in Beijing has found that problems with X chromosome inactivation, the process of silencing one of the female embryo’s X chromosomes, is responsible for much of this sex-ratio skew in mice. The team also demonstrated a method of reversing the male-dominant ratio by modifying the culture that murine preimplantation IVF embryos are grown in. The team’s results were published in PNAS today (March 7).

Paulo Rinaudo, a reproductive endocrinologist with the University of California, San Francisco, who was not involved in the study, noted that researchers previously suspected X chromosome inactivation played some role in this phenomenon. “The authors did a great job in going after a mechanism,” Rinaoudo wrote in an email.

In the U.S., around 1.5 percent of newborns are conceived via IVF. Elsewhere, the rate of IVF-conceived babies is as high as 4 percent. The assisted reproductive technology is also extensively used in cow, pig, and other livestock breeding programs, where researchers began documenting the skew toward male offspring in the early 1990s. In the past decade, a similar sex ratio has been found among human IVF embryos, but supporting evidence for the imbalance was inconsistent.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies